CLAB.F Share Price Performance
US$0.0001
-0.09 (-99.88%)
Price US$0.0001
Share PriceUS$0.0001
Core One Labs Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CLAB.F Community Narratives
There are no narratives available yet.
Recent CLAB.F News & Updates
Core One Labs Inc. Key Details
Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Core One Labs Inc. Competitors
Snowflake Analysis
About CLAB.F
- Founded
- 2010
- Employees
- n/a
- CEO
- WebsiteView website
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Canadian Market Performance
- 7 Days: -1.5%
- 3 Months: 8.0%
- 1 Year: 18.8%
- Year to Date: 18.4%
Over the last 7 days, the market has dropped 1.5%, driven by a loss of 2.0% in the Financials sector. In the last year, the market is actually up 19%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›